Literature DB >> 20453478

Surgical management of craniopharyngiomas in the pediatric population.

Gabriel Zada1, Edward R Laws.   

Abstract

BACKGROUND: Craniopharyngiomas (CPs) are benign, locally aggressive neoplasms that comprise approximately 10% of pediatric brain tumors. The role of surgical management for CPs is discussed in this review.
METHODS: A review of the goals and techniques associated with selected surgical approaches for the treatment of CPs in the pediatric population is provided.
RESULTS: CPs may be a cause of significant morbidity in children, requiring long-term, multimodal management by a team of specialists in order to optimize patient outcomes. Surgical intervention for CPs remains an important component of treatment, and depends upon establishing realistic and well-defined goals prior to any operation. Many transcranial and transsphenoidal approaches are available for approaching and resecting CPs. A summary of the rationale behind the timing and appropriateness of various surgical approaches, as well as associated benefits, pitfalls, and outcomes, is provided in this review.
CONCLUSION: Consistent longitudinal management by an interdisciplinary team can alter the treatment course in patients with CPs from a debilitating, morbid or lethal condition to a chronic, survivable disease with functional adult livelihood. Excellent outcomes in children with CPs are obtained only by close, frequent monitoring and by developing a keen sense of judgment regarding the appropriateness, timing and aggressiveness of any particular intervention. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20453478     DOI: 10.1159/000309349

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  7 in total

1.  Oxytocin in survivors of childhood-onset craniopharyngioma.

Authors:  Anna M M Daubenbüchel; Anika Hoffmann; Maria Eveslage; Jale Özyurt; Kristin Lohle; Julia Reichel; Christiane M Thiel; Henri Martens; Vincent Geenen; Hermann L Müller
Journal:  Endocrine       Date:  2016-09-01       Impact factor: 3.633

2.  Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma.

Authors:  Mohammed A Fouda; David Zurakowski; R Michael Scott; Karen J Marcus; Peter E Manley; Nicole J Ullrich; Laurie E Cohen; Liliana C Goumnerova
Journal:  Childs Nerv Syst       Date:  2020-09-04       Impact factor: 1.475

3.  Endonasal endoscopic skullbase surgery in children.

Authors:  Chandrashekhar E Deopujari; Nishit J Shah; Salman T Shaikh; Vikram S Karmarkar; Chandan B Mohanty
Journal:  Childs Nerv Syst       Date:  2019-05-12       Impact factor: 1.475

4.  Endoscopic extended transsphenoidal surgery for newly diagnosed paediatric craniopharyngiomas.

Authors:  Mohsen Javadpour; Michael Amoo; Darach Crimmins; John Caird; Patricia Daly; Jane Pears; Cormac Owens; Michael Capra; Declan Cody
Journal:  Childs Nerv Syst       Date:  2021-03-05       Impact factor: 1.475

5.  Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation.

Authors:  Zheng Shi; Natia Esiashvili; Anna J Janss; Claire M Mazewski; Tobey J MacDonald; David M Wrubel; Barunashish Brahma; Frederick P Schwaibold; Robert B Marcus; Ian R Crocker; Hui-Kuo G Shu
Journal:  J Neurooncol       Date:  2012-06-13       Impact factor: 4.130

6.  Risk factors associated with the surgical management of craniopharyngiomas in pediatric patients: analysis of 1961 patients from a national registry database.

Authors:  Joshua Bakhsheshian; Diana L Jin; Ki-Eun Chang; Ben A Strickland; Dan A Donoho; Steven Cen; William J Mack; Frank Attenello; Eisha A Christian; Gabriel Zada
Journal:  Neurosurg Focus       Date:  2016-12       Impact factor: 4.047

Review 7.  Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review.

Authors:  Gabriel Zada; Natalie Kintz; Mario Pulido; Lilyana Amezcua
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.